NextPlat (NXPL) Cash & Equivalents (2014 - 2026)
NextPlat (NXPL) recorded Cash & Equivalents of $11.94 million in Q2 2026, down 28.2% from $16.64 million a year earlier but up 8.5% from the prior quarter.
NextPlat (NXPL) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, NextPlat reported Cash & Equivalents of $13.71 million, down 31.3% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 79.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $19.96 million in FY2024 (-24.1%), $26.31 million in FY2023 (+39.3%), $18.89 million in FY2022 (+9.4%) and $17.27 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $11.01 million in Q1 2026 to $26.35 million in Q3 2023 over the past five years.
- On a year-over-year basis, Cash & Equivalents has declined for eight consecutive quarters, with an average decline of 29.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 111.3% in Q3 2023, against a decline of 37.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.01 million (Q1 2026), $13.71 million (Q4 2025) and $13.93 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | NextPlat | 23.20 Mn | -27.28 Mn | 4.69 Mn | 11.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.94 Mn |
| Mar 31, 2026 | 11.01 Mn |
| Dec 31, 2025 | 13.71 Mn |
| Sep 30, 2025 | 13.93 Mn |
| Jun 30, 2025 | 16.64 Mn |
| Mar 31, 2025 | 17.74 Mn |
| Dec 31, 2024 | 19.96 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Jun 30, 2024 | 24.88 Mn |
| Mar 31, 2024 | 23.53 Mn |
| Dec 31, 2023 | 26.31 Mn |
| Sep 30, 2023 | 26.35 Mn |
| Jun 30, 2023 | 20.61 Mn |
| Mar 31, 2023 | 16.72 Mn |
| Dec 31, 2022 | 18.89 Mn |
| Sep 30, 2022 | 12.47 Mn |
| Jun 30, 2022 | 20.47 Mn |
| Mar 31, 2022 | 21.91 Mn |
| Dec 31, 2021 | 17.27 Mn |
| Sep 30, 2021 | 17.14 Mn |
NextPlat Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXPL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NXPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();